Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0190 Transporter Info | ||||
Gene Name | SLC25A29 | ||||
Transporter Name | Mitochondrial ornithine transporter 3 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Pancretic ductal adenocarcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg18710929) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.32E+00 | Statistic Test | p-value: 2.75E-25; Z-score: 6.45E+00 | ||
Methylation in Case |
2.25E-01 (Median) | Methylation in Control | 9.69E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A29 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg04012082) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.51E+00 | Statistic Test | p-value: 2.69E-15; Z-score: -2.53E+00 | ||
Methylation in Case |
2.68E-01 (Median) | Methylation in Control | 4.05E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A29 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg15175242) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 4.15E-08; Z-score: -6.42E-01 | ||
Methylation in Case |
8.53E-01 (Median) | Methylation in Control | 8.68E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A29 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg01740650) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.89E-03; Z-score: -2.84E-01 | ||
Methylation in Case |
8.91E-01 (Median) | Methylation in Control | 8.96E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A29 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg10786489) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.46E-02; Z-score: -2.83E-01 | ||
Methylation in Case |
8.36E-01 (Median) | Methylation in Control | 8.41E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in hepatocellular carcinoma | [ 2 ] | |||
Location |
TSS200 (cg04299028) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.73E+00 | Statistic Test | p-value: 1.44E-18; Z-score: -5.34E+00 | ||
Methylation in Case |
4.03E-01 (Median) | Methylation in Control | 6.98E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A29 in hepatocellular carcinoma | [ 2 ] | |||
Location |
TSS200 (cg21306329) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.45E+00 | Statistic Test | p-value: 5.49E-15; Z-score: 1.83E+00 | ||
Methylation in Case |
6.34E-01 (Median) | Methylation in Control | 4.39E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A29 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg23709172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.18E+00 | Statistic Test | p-value: 2.66E-06; Z-score: 1.36E+00 | ||
Methylation in Case |
5.55E-01 (Median) | Methylation in Control | 4.70E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A29 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg01551177) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.21E-03; Z-score: -3.37E-01 | ||
Methylation in Case |
7.01E-01 (Median) | Methylation in Control | 7.17E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A29 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg14064024) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 3.50E-02; Z-score: 8.91E-01 | ||
Methylation in Case |
6.67E-01 (Median) | Methylation in Control | 6.13E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A29 in hepatocellular carcinoma | [ 2 ] | |||
Location |
3'UTR (cg20929849) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 2.72E-05; Z-score: -1.37E+00 | ||
Methylation in Case |
8.12E-01 (Median) | Methylation in Control | 8.47E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in prostate cancer | [ 3 ] | |||
Location |
TSS200 (cg21977075) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.53E+00 | Statistic Test | p-value: 1.82E-02; Z-score: 2.44E+00 | ||
Methylation in Case |
7.37E-01 (Median) | Methylation in Control | 4.82E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A29 in prostate cancer | [ 3 ] | |||
Location |
Body (cg20955989) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.57E+00 | Statistic Test | p-value: 3.80E-02; Z-score: 6.49E+00 | ||
Methylation in Case |
5.17E-01 (Median) | Methylation in Control | 2.01E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A29 in prostate cancer | [ 3 ] | |||
Location |
3'UTR (cg07501827) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 1.54E-03; Z-score: 3.61E+00 | ||
Methylation in Case |
8.49E-01 (Median) | Methylation in Control | 7.50E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in colon adenocarcinoma | [ 4 ] | |||
Location |
1stExon (cg12348970) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 2.56E-03; Z-score: -2.60E+00 | ||
Methylation in Case |
8.05E-01 (Median) | Methylation in Control | 8.56E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A29 in colon adenocarcinoma | [ 4 ] | |||
Location |
Body (cg13960084) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.97E+00 | Statistic Test | p-value: 2.03E-07; Z-score: 6.58E+00 | ||
Methylation in Case |
4.48E-01 (Median) | Methylation in Control | 1.51E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A29 in colon adenocarcinoma | [ 4 ] | |||
Location |
Body (cg07489029) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 8.61E-04; Z-score: -2.12E+00 | ||
Methylation in Case |
8.11E-01 (Median) | Methylation in Control | 8.70E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A29 in colon adenocarcinoma | [ 4 ] | |||
Location |
Body (cg11828251) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 1.97E-03; Z-score: -2.53E+00 | ||
Methylation in Case |
7.04E-01 (Median) | Methylation in Control | 7.86E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A29 in colon adenocarcinoma | [ 4 ] | |||
Location |
Body (cg12096528) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 2.46E-03; Z-score: -1.11E+00 | ||
Methylation in Case |
8.23E-01 (Median) | Methylation in Control | 8.45E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in atypical teratoid rhabdoid tumor | [ 5 ] | |||
Location |
Body (cg01437482) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 6.81E-05; Z-score: 5.98E-01 | ||
Methylation in Case |
8.74E-01 (Median) | Methylation in Control | 8.12E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A29 in atypical teratoid rhabdoid tumor | [ 5 ] | |||
Location |
Body (cg01551177) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 7.33E-05; Z-score: -1.08E+00 | ||
Methylation in Case |
6.31E-01 (Median) | Methylation in Control | 7.35E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A29 in atypical teratoid rhabdoid tumor | [ 5 ] | |||
Location |
Body (cg03886017) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 4.60E-04; Z-score: -7.63E-01 | ||
Methylation in Case |
5.82E-01 (Median) | Methylation in Control | 7.04E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A29 in atypical teratoid rhabdoid tumor | [ 5 ] | |||
Location |
Body (cg05043627) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.22E-03; Z-score: -5.53E-01 | ||
Methylation in Case |
8.19E-01 (Median) | Methylation in Control | 8.43E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A29 in atypical teratoid rhabdoid tumor | [ 5 ] | |||
Location |
Body (cg14064024) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 4.24E-02; Z-score: 3.19E-01 | ||
Methylation in Case |
9.04E-01 (Median) | Methylation in Control | 8.80E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A29 in atypical teratoid rhabdoid tumor | [ 5 ] | |||
Location |
Body (cg14318489) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 4.49E-02; Z-score: -7.96E-02 | ||
Methylation in Case |
4.17E-02 (Median) | Methylation in Control | 4.36E-02 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A29 in atypical teratoid rhabdoid tumor | [ 5 ] | |||
Location |
3'UTR (cg15862841) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 6.67E-11; Z-score: -1.64E+00 | ||
Methylation in Case |
8.30E-01 (Median) | Methylation in Control | 8.67E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A29 in atypical teratoid rhabdoid tumor | [ 5 ] | |||
Location |
3'UTR (cg20929849) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 4.82E-10; Z-score: 1.90E+00 | ||
Methylation in Case |
8.37E-01 (Median) | Methylation in Control | 6.73E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in bladder cancer | [ 6 ] | |||
Location |
Body (cg23709172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.42E+00 | Statistic Test | p-value: 2.96E-08; Z-score: 7.27E+00 | ||
Methylation in Case |
4.98E-01 (Median) | Methylation in Control | 2.06E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A29 in bladder cancer | [ 6 ] | |||
Location |
Body (cg01551177) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.43E+00 | Statistic Test | p-value: 5.11E-08; Z-score: -9.23E+00 | ||
Methylation in Case |
5.59E-01 (Median) | Methylation in Control | 8.01E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A29 in bladder cancer | [ 6 ] | |||
Location |
Body (cg05043627) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.87E+00 | Statistic Test | p-value: 9.76E-06; Z-score: -4.45E+00 | ||
Methylation in Case |
1.06E-01 (Median) | Methylation in Control | 1.98E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A29 in bladder cancer | [ 6 ] | |||
Location |
Body (cg14064024) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.23E+00 | Statistic Test | p-value: 2.38E-04; Z-score: -3.44E+00 | ||
Methylation in Case |
4.28E-01 (Median) | Methylation in Control | 5.26E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A29 in bladder cancer | [ 6 ] | |||
Location |
Body (cg17705681) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 2.60E-04; Z-score: -7.45E+00 | ||
Methylation in Case |
8.93E-01 (Median) | Methylation in Control | 9.17E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A29 in bladder cancer | [ 6 ] | |||
Location |
Body (cg18804587) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 6.03E-03; Z-score: 2.15E+00 | ||
Methylation in Case |
9.51E-01 (Median) | Methylation in Control | 9.26E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC25A29 in bladder cancer | [ 6 ] | |||
Location |
Body (cg24141378) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 2.07E-02; Z-score: -1.57E+00 | ||
Methylation in Case |
8.22E-01 (Median) | Methylation in Control | 8.38E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC25A29 in bladder cancer | [ 6 ] | |||
Location |
Body (cg25906332) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 2.58E-02; Z-score: -1.67E+00 | ||
Methylation in Case |
5.08E-02 (Median) | Methylation in Control | 5.99E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC25A29 in bladder cancer | [ 6 ] | |||
Location |
3'UTR (cg20929849) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 4.07E-02; Z-score: -1.25E+00 | ||
Methylation in Case |
8.11E-01 (Median) | Methylation in Control | 8.26E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in breast cancer | [ 7 ] | |||
Location |
Body (cg01551177) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 1.44E-11; Z-score: -2.56E+00 | ||
Methylation in Case |
7.04E-01 (Median) | Methylation in Control | 7.86E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A29 in breast cancer | [ 7 ] | |||
Location |
Body (cg05043627) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.49E+00 | Statistic Test | p-value: 6.34E-09; Z-score: -1.62E+00 | ||
Methylation in Case |
1.21E-01 (Median) | Methylation in Control | 1.79E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A29 in breast cancer | [ 7 ] | |||
Location |
Body (cg23709172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 1.20E-07; Z-score: 1.72E+00 | ||
Methylation in Case |
2.75E-01 (Median) | Methylation in Control | 2.28E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A29 in breast cancer | [ 7 ] | |||
Location |
Body (cg14064024) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 5.62E-07; Z-score: -1.23E+00 | ||
Methylation in Case |
4.86E-01 (Median) | Methylation in Control | 5.44E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A29 in breast cancer | [ 7 ] | |||
Location |
Body (cg18629527) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.33E+00 | Statistic Test | p-value: 2.88E-05; Z-score: 1.14E+00 | ||
Methylation in Case |
1.87E-01 (Median) | Methylation in Control | 1.40E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A29 in breast cancer | [ 7 ] | |||
Location |
3'UTR (cg20929849) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.49E-02; Z-score: 1.66E+00 | ||
Methylation in Case |
8.44E-01 (Median) | Methylation in Control | 7.96E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in clear cell renal cell carcinoma | [ 8 ] | |||
Location |
Body (cg18629527) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.08E+00 | Statistic Test | p-value: 1.40E-08; Z-score: 2.06E+00 | ||
Methylation in Case |
2.16E-01 (Median) | Methylation in Control | 1.04E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A29 in clear cell renal cell carcinoma | [ 8 ] | |||
Location |
Body (cg20299151) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 5.49E-03; Z-score: -5.59E-01 | ||
Methylation in Case |
9.81E-01 (Median) | Methylation in Control | 9.82E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A29 in clear cell renal cell carcinoma | [ 8 ] | |||
Location |
Body (cg14064024) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 1.26E-02; Z-score: -1.11E+00 | ||
Methylation in Case |
5.87E-01 (Median) | Methylation in Control | 6.41E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A29 in clear cell renal cell carcinoma | [ 8 ] | |||
Location |
Body (cg24141378) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 1.70E-02; Z-score: -2.89E-01 | ||
Methylation in Case |
9.41E-01 (Median) | Methylation in Control | 9.44E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A29 in clear cell renal cell carcinoma | [ 8 ] | |||
Location |
Body (cg14318489) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 1.79E-02; Z-score: -1.52E-01 | ||
Methylation in Case |
9.81E-01 (Median) | Methylation in Control | 9.81E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC25A29 in clear cell renal cell carcinoma | [ 8 ] | |||
Location |
Body (cg17705681) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 4.86E-02; Z-score: -3.68E-01 | ||
Methylation in Case |
9.74E-01 (Median) | Methylation in Control | 9.76E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in colorectal cancer | [ 9 ] | |||
Location |
Body (cg01551177) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 1.34E-10; Z-score: -4.00E+00 | ||
Methylation in Case |
7.56E-01 (Median) | Methylation in Control | 8.59E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A29 in colorectal cancer | [ 9 ] | |||
Location |
Body (cg14318489) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 1.81E-04; Z-score: -1.16E+00 | ||
Methylation in Case |
9.76E-01 (Median) | Methylation in Control | 9.79E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A29 in colorectal cancer | [ 9 ] | |||
Location |
Body (cg14064024) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 6.80E-04; Z-score: 1.28E+00 | ||
Methylation in Case |
7.01E-01 (Median) | Methylation in Control | 5.99E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A29 in colorectal cancer | [ 9 ] | |||
Location |
Body (cg24141378) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 1.64E-02; Z-score: -9.23E-02 | ||
Methylation in Case |
9.31E-01 (Median) | Methylation in Control | 9.32E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A29 in colorectal cancer | [ 9 ] | |||
Location |
Body (cg16073846) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 2.40E-02; Z-score: -5.63E-01 | ||
Methylation in Case |
1.89E-02 (Median) | Methylation in Control | 2.36E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Depression |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in depression | [ 10 ] | |||
Location |
Body (cg18804587) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 1.62E-02; Z-score: 3.54E-01 | ||
Methylation in Case |
9.18E-01 (Median) | Methylation in Control | 9.12E-01 (Median) | ||
Studied Phenotype |
Depression [ ICD-11: 6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A29 in depression | [ 10 ] | |||
Location |
Body (cg14318489) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 2.19E-02; Z-score: -4.23E-01 | ||
Methylation in Case |
9.48E-01 (Median) | Methylation in Control | 9.51E-01 (Median) | ||
Studied Phenotype |
Depression [ ICD-11: 6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in HIV infection | [ 11 ] | |||
Location |
Body (cg14064024) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.28E+00 | Statistic Test | p-value: 8.69E-10; Z-score: 2.10E+00 | ||
Methylation in Case |
5.65E-01 (Median) | Methylation in Control | 4.42E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A29 in HIV infection | [ 11 ] | |||
Location |
Body (cg18629527) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.53E+00 | Statistic Test | p-value: 2.86E-07; Z-score: 1.82E+00 | ||
Methylation in Case |
3.10E-01 (Median) | Methylation in Control | 2.03E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A29 in HIV infection | [ 11 ] | |||
Location |
Body (cg23709172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.39E+00 | Statistic Test | p-value: 1.11E-05; Z-score: 2.36E+00 | ||
Methylation in Case |
3.22E-01 (Median) | Methylation in Control | 2.31E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A29 in HIV infection | [ 11 ] | |||
Location |
Body (cg18804587) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 5.48E-05; Z-score: 5.78E-01 | ||
Methylation in Case |
9.62E-01 (Median) | Methylation in Control | 9.55E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A29 in HIV infection | [ 11 ] | |||
Location |
Body (cg01551177) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 2.61E-04; Z-score: -1.51E+00 | ||
Methylation in Case |
7.59E-01 (Median) | Methylation in Control | 8.23E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in lung adenocarcinoma | [ 12 ] | |||
Location |
Body (cg01551177) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 3.11E-04; Z-score: -2.65E+00 | ||
Methylation in Case |
7.74E-01 (Median) | Methylation in Control | 8.45E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A29 in lung adenocarcinoma | [ 12 ] | |||
Location |
Body (cg18629527) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.52E+00 | Statistic Test | p-value: 3.51E-03; Z-score: 2.70E+00 | ||
Methylation in Case |
3.68E-01 (Median) | Methylation in Control | 2.43E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A29 in lung adenocarcinoma | [ 12 ] | |||
Location |
Body (cg23709172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.26E+00 | Statistic Test | p-value: 1.08E-02; Z-score: 1.98E+00 | ||
Methylation in Case |
2.76E-01 (Median) | Methylation in Control | 2.20E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in panic disorder | [ 13 ] | |||
Location |
Body (cg01551177) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 6.00E-03; Z-score: 6.11E-01 | ||
Methylation in Case |
2.25E+00 (Median) | Methylation in Control | 1.95E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in papillary thyroid cancer | [ 14 ] | |||
Location |
Body (cg23709172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 8.51E-05; Z-score: 7.94E-01 | ||
Methylation in Case |
1.65E-01 (Median) | Methylation in Control | 1.43E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A29 in papillary thyroid cancer | [ 14 ] | |||
Location |
Body (cg18629527) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 1.56E-03; Z-score: 6.29E-01 | ||
Methylation in Case |
1.25E-01 (Median) | Methylation in Control | 1.04E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A29 in papillary thyroid cancer | [ 14 ] | |||
Location |
Body (cg01551177) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.76E-02; Z-score: -9.06E-02 | ||
Methylation in Case |
7.96E-01 (Median) | Methylation in Control | 8.00E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC25A29 in papillary thyroid cancer | [ 14 ] | |||
Location |
Body (cg18804587) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.00E+00 | Statistic Test | p-value: 4.27E-02; Z-score: 1.82E-01 | ||
Methylation in Case |
9.27E-01 (Median) | Methylation in Control | 9.25E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC25A29 in papillary thyroid cancer | [ 14 ] | |||
Location |
3'UTR (cg15862841) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 1.32E-11; Z-score: 1.64E+00 | ||
Methylation in Case |
9.32E-01 (Median) | Methylation in Control | 8.70E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC25A29 in systemic lupus erythematosus | [ 15 ] | |||
Location |
Body (cg18629527) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 1.47E-02; Z-score: 1.68E-01 | ||
Methylation in Case |
3.03E-01 (Median) | Methylation in Control | 2.84E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC25A29 in systemic lupus erythematosus | [ 15 ] | |||
Location |
Body (cg03886017) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 2.98E-02; Z-score: -3.20E-02 | ||
Methylation in Case |
9.27E-01 (Median) | Methylation in Control | 9.28E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC25A29 in systemic lupus erythematosus | [ 15 ] | |||
Location |
Body (cg01551177) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 3.70E-02; Z-score: -2.73E-01 | ||
Methylation in Case |
7.68E-01 (Median) | Methylation in Control | 8.01E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-15a directly targets SLC25A29 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-15a | miRNA Mature ID | miR-15a-5p | ||
miRNA Sequence |
UAGCAGCACAUAAUGGUUUGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 2 |
miR-15b directly targets SLC25A29 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-15b | miRNA Mature ID | miR-15b-5p | ||
miRNA Sequence |
UAGCAGCACAUCAUGGUUUACA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 3 |
miR-16 directly targets SLC25A29 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-16 | miRNA Mature ID | miR-16-5p | ||
miRNA Sequence |
UAGCAGCACGUAAAUAUUGGCG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 4 |
miR-195 directly targets SLC25A29 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-195 | miRNA Mature ID | miR-195-5p | ||
miRNA Sequence |
UAGCAGCACAGAAAUAUUGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.